Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted nanoliposomes to improve enzyme replacement therapy of Fabry disease.
Tomsen-Melero J, Moltó-Abad M, Merlo-Mas J, Díaz-Riascos ZV, Cristóbal-Lecina E, Soldevila A, Altendorfer-Kroath T, Danino D, Ionita I, Pedersen JS, Snelling L, Clay H, Carreño A, Corchero JL, Pulido D, Casas J, Veciana J, Simó Schwartz Jr, Sala S, Font A, Birngruber T, Royo M, Córdoba A, Ventosa N, Abasolo I, González-Mira E. Tomsen-Melero J, et al. Among authors: royo m. Sci Adv. 2024 Dec 13;10(50):eadq4738. doi: 10.1126/sciadv.adq4738. Epub 2024 Dec 13. Sci Adv. 2024. PMID: 39671483 Free article.
A Cyclic Peptide Targets Glioblastoma by Binding to Aberrantly Exposed SNAP25.
Arias AG, Tovar-Martinez L, Asciutto EK, Mann A, Põšnograjeva K, Gracia LS, Royo M, Haugas M, Teesalu T, Smulski C, Ruoslahti E, Scodeller P. Arias AG, et al. Among authors: royo m. Mol Pharm. 2025 Jan 6;22(1):363-376. doi: 10.1021/acs.molpharmaceut.4c00958. Epub 2024 Nov 22. Mol Pharm. 2025. PMID: 39575977
A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25.
Arias AG, Tovar-Martinez L, Asciutto E, Mann A, Posnograjeva K, Gracia LS, Royo M, Haugas M, Teesalu T, Smulski C, Ruoslahti E, Scodeller P. Arias AG, et al. Among authors: royo m. bioRxiv [Preprint]. 2024 Sep 21:2024.09.18.613627. doi: 10.1101/2024.09.18.613627. bioRxiv. 2024. Update in: Mol Pharm. 2025 Jan 6;22(1):363-376. doi: 10.1021/acs.molpharmaceut.4c00958 PMID: 39345514 Free PMC article. Updated. Preprint.
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models.
Puighermanal E, Luna-Sánchez M, Gella A, van der Walt G, Urpi A, Royo M, Tena-Morraja P, Appiah I, de Donato MH, Menardy F, Bianchi P, Esteve-Codina A, Rodríguez-Pascau L, Vergara C, Gómez-Pallarès M, Marsicano G, Bellocchio L, Martinell M, Sanz E, Jurado S, Soriano FX, Pizcueta P, Quintana A. Puighermanal E, et al. Among authors: royo m. Nat Commun. 2024 Sep 4;15(1):7730. doi: 10.1038/s41467-024-51884-8. Nat Commun. 2024. PMID: 39231983 Free PMC article.
195 results